Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 22,500 | |||
5 mg | 在庫あり | ¥ 57,000 | |||
10 mg | 在庫あり | ¥ 91,500 | |||
25 mg | 在庫あり | ¥ 152,500 | |||
50 mg | 在庫あり | ¥ 217,000 | |||
100 mg | 在庫あり | ¥ 294,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 62,500 |
説明 | CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer. |
ターゲット&IC50 | CD73:28 nM |
別名 | EX-A4254, LY-3475070 |
分子量 | 286.33 |
分子式 | C15H18N4O2 |
CAS No. | 2375815-63-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (78.58 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CD73-IN-3 2375815-63-5 Immunology/Inflammation CD73 Inhibitor cancer LY 3475070 CD73 IN 3 LY3475070 CD-73-IN-3 EX-A 4254 CD73IN3 EX-A-4254 EX-A4254 Immunosuppression tumor inhibit LY-3475070 inhibitor